Content about GlaxoSmithKline

December 7, 2011
FDA modifies REMS for two drugs to treat low platelet counts

Prescribers, patients and specialty care centers no longer will be required to enroll in safety monitoring programs for two drugs used to treat low platelet counts, following changes to their risk evaluation and mitigation strategies.

November 17, 2011
GSK announces results of late-stage clinical trial for albiglutide

GlaxoSmithKline announced the results from the first of eight phase-3 clinical trials that examined the efficacy of albiglutide in the treatment of Type 2 diabetes.

November 17, 2011
Kline: Consumers gravitating toward 'natural' OTCs

Consumers are gravitating toward "natural" over-the-counter remedies, according to a new Kline report, "Natural OTCs 2011: Impact of Non-Drug Products on the U.S. OTC Market," released Wednesday.

November 11, 2011
Pawlenty and ‘who’s who’ of retail pharmacy headline 13th annual Issues Summit

The list of participating companies in the 13th Annual Drug Store News Group Industry Issues conference — which will be held Tuesday, Nov. 29, at the highly prestigious New York Athletic Club — reads like a “who’s who” of pharmacy retailing.

November 10, 2011
Signum, GSK enter collaborative agreement

Biotechnology company Signum Biosciences has entered a collaborative agreement with GlaxoSmithKline whereby GSK will receive the exclusive right to Signum's proprietary phosphatase screening technology.

November 9, 2011
Mylan acquires rights to Pfizer's inhaler technology

Generic drug maker Mylan has bought rights to a drug delivery platform made by Pfizer that will allow it to make generic versions of two GlaxoSmithKline respiratory drugs, Mylan said Wednesday.

November 8, 2011
Stiefel develops new Revaleskin HydraLift Complex anti-aging treatment

Stiefel, a GlaxoSmithKline company, has expanded its Revaleskin portfolio with the new Revaleskin HydraLift Complex.

October 27, 2011
Dynavax releases results of hepatitis B vaccine phase-3 trial

An experimental vaccine for hepatitis B made by Dynavax Technologies appears to work better in patients with diabetes than current treatments, the company said.

October 11, 2011
Antacids expect some upset

Sales of antacid tablets are up almost 3%. And while nobody is suggesting that upward trajectory is going to change anytime soon, there will be a decent amount of volatility in the coming year.


October 11, 2011
‘Regular’ sales increases

Sales in the digestives aisle going forward look positive, especially as an aging population begins paying closer attention to healthy diets, including the right amount of dietary fiber to keep things “regular” and supplementation with probiotics for overall digestive health.


October 4, 2011
Study: Asthma, COPD markets to see revenue growth, innovation

Growing numbers of Americans with asthma and chronic obstructive pulmonary disease are driving innovation among drug makers, according to a new report by Frost & Sullivan.

September 29, 2011
FDA declines to approve GSK vaccine

The Food and Drug Administration has declined to approve a vaccine developed by GlaxoSmithKline, the drug maker said.

September 16, 2011
GSK announces strategic partnership with McLaren

GlaxoSmithKline and McLaren Group have entered a long-term strategic partnership.

September 15, 2011
GSK donates more than $1 million to fight HPV

GlaxoSmithKline is making a donation that it said would give more than 10,000 girls and women access to human papillomavirus vaccination.

September 15, 2011
GSK, Amicus start phase-3 trial of Fabry disease drug

GlaxoSmithKline and Amicus Therapeutics have started a late-stage clinical trial for a drug to treat a rare genetic disorder, the companies said.

September 13, 2011
GSK Consumer Healthcare taps new chief customer officer

GlaxoSmithKline's Consumer Healthcare division has appointed a former Kraft Foods executive as its new chief customer officer.

September 13, 2011
Impax confirms patent challenge for generic Jalyn

Impax Labs has hit a roadblock in its attempt to market a generic version of a symptomatic benign prostatic hyperplasia drug.

September 12, 2011
Flip the switch


As the clock winds down on the patent exclusivity of the industry’s biggest blockbuster drug in November, speculation continues to grow that Pfizer will look to flip the switch on an OTC version of Lipitor (atorvastatin) before generic competition whittles away at the $7 billion behemoth. 


September 12, 2011
Taking it to-go

Portable oral care continues to experience strong growth and, if prior sales periods are any indication of what’s ahead, the segment will likely continue to flourish.

September 12, 2011
Toothpastes help polish sales

The expansive oral care market continues to swell as manufacturers further develop toothpastes that promise to provide specific results.

September 1, 2011
GSK announces VP sales Clark Brown departure

GlaxoSmithKline on Thursday announced that 25-year veteran Clark Brown, VP sales at GSK Consumer Healthcare, will be leaving the organization effective Sept. 2.

August 15, 2011
Study: Investigational GSK, Impax drug reduces Parkinson's symptoms

Patients taking an experimental treatment for Parkinson's disease experienced greater reduction in symptoms than those taking standard therapies, according to results of a late-stage clinical trial.

August 11, 2011
GSK, XenoPort file sNDA for Horizant

Drug makers GlaxoSmithKline and XenoPort are seeking expanded approval for their restless legs syndrome treatment.

August 9, 2011
GSK names new chief marketing officer

GlaxoSmithKline Consumer Healthcare on Monday named John Graham chief marketing officer for Consumer Healthcare, North America.

August 4, 2011
Stiefel seeks FDA approval for tazarotene foam

GlaxoSmithKline company Stiefel announced it is seeking approval for a facial acne treatment in patients ages 12 years and older.

© 2013 Drug Store News. All Rights Reserved.